When combined with clinical data, FAK expression levels are found to correlate with prognostic levels in tumors such as liver cancer, gastric cancer, colorectal cancer, bladder cancer, OSCC, breast cancer, thyroid cancer, AML, and melanoma; therefore, FAK has essential qualities as a prognostic marker. Here, PTK2 is linked to urinary bladder cancer.